ID   NISCH_RAT               Reviewed;        1502 AA.
AC   Q4G017;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   29-MAY-2024, entry version 109.
DE   RecName: Full=Nischarin;
DE   AltName: Full=Imidazoline receptor 1;
DE            Short=I-1;
DE            Short=IR1;
DE   AltName: Full=Imidazoline-1 receptor;
DE            Short=I1R;
GN   Name=Nisch;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1287-1502.
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=11274989; DOI=10.1016/s0014-2999(01)00834-2;
RA   Zhang J., El-Mas M.M., Abdel-Rahman A.A.;
RT   "Imidazoline I(1) receptor-induced activation of phosphatidylcholine-
RT   specific phospholipase C elicits mitogen-activated protein kinase
RT   phosphorylation in PC12 cells.";
RL   Eur. J. Pharmacol. 415:117-125(2001).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15901801; DOI=10.1124/jpet.105.087510;
RA   Zhang J., Abdel-Rahman A.A.;
RT   "Mitogen-activated protein kinase phosphorylation in the rostral
RT   ventrolateral medulla plays a key role in imidazoline (I1)-receptor-
RT   mediated hypotension.";
RL   J. Pharmacol. Exp. Ther. 314:945-952(2005).
RN   [5]
RP   FUNCTION.
RX   PubMed=17254010; DOI=10.1111/j.1471-4159.2006.04413.x;
RA   Sun Z., Chang C.-H., Ernsberger P.;
RT   "Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat
RT   pheochromocytoma cells.";
RL   J. Neurochem. 101:99-108(2007).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17940198; DOI=10.1124/jpet.107.129049;
RA   Zhang J., Abdel-Rahman A.A.;
RT   "Inhibition of nischarin expression attenuates rilmenidine-evoked
RT   hypotension and phosphorylated extracellular signal-regulated kinase 1/2
RT   production in the rostral ventrolateral medulla of rats.";
RL   J. Pharmacol. Exp. Ther. 324:72-78(2008).
CC   -!- FUNCTION: Acts either as the functional imidazoline-1 receptor (I1R)
CC       candidate or as a membrane-associated mediator of the I1R signaling.
CC       Binds numerous imidazoline ligands that induces initiation of cell-
CC       signaling cascades triggering to cell survival, growth and migration.
CC       Its activation by the agonist rilmenidine induces an increase in
CC       phosphorylation of mitogen-activated protein kinases MAPK1 and MAPK3 in
CC       rostral ventrolateral medulla (RVLM) neurons that exhibited
CC       rilmenidine-evoked hypotension. Blocking its activation with efaroxan
CC       abolished rilmenidine-induced mitogen-activated protein kinase
CC       phosphorylation in RVLM neurons. Acts as a modulator of Rac-regulated
CC       signal transduction pathways (By similarity). Suppresses Rac1-
CC       stimulated cell migration by interacting with PAK1 and inhibiting its
CC       kinase activity (By similarity). Also blocks Pak-independent Rac
CC       signaling by interacting with RAC1 and inhibiting Rac1-stimulated NF-kB
CC       response element and cyclin D1 promoter activation (By similarity).
CC       Inhibits also LIMK1 kinase activity by reducing LIMK1 'Tyr-508'
CC       phosphorylation (By similarity). Inhibits Rac-induced cell migration
CC       and invasion in breast and colon epithelial cells (By similarity).
CC       Inhibits lamellipodia formation, when overexpressed (By similarity).
CC       Plays a role in protection against apoptosis (By similarity). Involved
CC       in association with IRS4 in the enhancement of insulin activation of
CC       MAPK1 and MAPK3 (By similarity). When overexpressed, induces a
CC       redistribution of cell surface ITGA5 integrin to intracellular
CC       endosomal structures (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:11274989, ECO:0000269|PubMed:15901801,
CC       ECO:0000269|PubMed:17254010, ECO:0000269|PubMed:17940198}.
CC   -!- SUBUNIT: Homooligomer. Interacts with GRB2. Interacts with PIK3R1;
CC       probably associates with the PI3-kinase complex. Interacts with IRS4.
CC       Found in a complex with ITGA5 and PAK1. Found in a complex with LIMK1
CC       and PAK1. Interacts with ITGA5 (via cytoplasmic domain); this
CC       interaction is direct. Interacts with PAK1 (via kinase domain); this
CC       interaction is direct and is increased upon activation of PAK1.
CC       Interacts with LIMK1 (via PDZ and kinase domain); this interaction is
CC       direct. Interacts with LIMK2; this interaction depends on LIMK2
CC       activity. Interacts with RAC1 (activated state) (By similarity).
CC       Interacts with STK11; this interaction may increase STK11 activity (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Early endosome {ECO:0000250}. Recycling endosome
CC       {ECO:0000250}. Note=Enriched in the early/sorting and recycling
CC       endosomes. Colocalized in early/sorting endosomes with EEA1 and SNX2
CC       and in recycling endosomes with transferrin receptor. Detected in the
CC       perinuclear region partially associated with punctate structures.
CC       Colocalizes with PAK1 in cytoplasm, vesicular structures in the
CC       perinuclear area and membrane ruffles. Colocalizes with RAC1 in the
CC       cytoplasm and vesicles structures (By similarity). Colocalized with
CC       MAPK1 and MAPK3 in RVLM neurons. {ECO:0000250,
CC       ECO:0000269|PubMed:15901801, ECO:0000269|PubMed:17940198}.
CC   -!- DOMAIN: Both the presence of the PX domain and the coiled coil region
CC       are necessary for its endosomal targeting. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03100261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC098837; AAH98837.1; -; mRNA.
DR   AlphaFoldDB; Q4G017; -.
DR   SMR; Q4G017; -.
DR   IntAct; Q4G017; 3.
DR   MINT; Q4G017; -.
DR   STRING; 10116.ENSRNOP00000032758; -.
DR   BindingDB; Q4G017; -.
DR   ChEMBL; CHEMBL5221; -.
DR   DrugCentral; Q4G017; -.
DR   iPTMnet; Q4G017; -.
DR   PhosphoSitePlus; Q4G017; -.
DR   jPOST; Q4G017; -.
DR   PaxDb; 10116-ENSRNOP00000032758; -.
DR   UCSC; RGD:1306950; rat.
DR   AGR; RGD:1306950; -.
DR   RGD; 1306950; Nisch.
DR   VEuPathDB; HostDB:ENSRNOG00000018823; -.
DR   eggNOG; KOG1259; Eukaryota.
DR   HOGENOM; CLU_252294_0_0_1; -.
DR   InParanoid; Q4G017; -.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9696264; RND3 GTPase cycle.
DR   Reactome; R-RNO-9696270; RND2 GTPase cycle.
DR   PRO; PR:Q4G017; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000018823; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0043014; F:alpha-tubulin binding; IBA:GO_Central.
DR   GO; GO:0045504; F:dynein heavy chain binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006006; P:glucose metabolic process; IMP:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0048243; P:norepinephrine secretion; IMP:RGD.
DR   GO; GO:0036158; P:outer dynein arm assembly; IBA:GO_Central.
DR   GO; GO:0016601; P:Rac protein signal transduction; ISO:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:RGD.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IMP:RGD.
DR   CDD; cd06875; PX_IRAS; 1.
DR   Gene3D; 3.30.1520.10; Phox-like domain; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR037904; Nischarin_PX.
DR   InterPro; IPR001683; PX_dom.
DR   InterPro; IPR036871; PX_dom_sf.
DR   PANTHER; PTHR15454:SF35; NISCHARIN; 1.
DR   PANTHER; PTHR15454; NISCHARIN RELATED; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00365; LRR_SD22; 5.
DR   SMART; SM00369; LRR_TYP; 4.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF52075; Outer arm dynein light chain 1; 1.
DR   SUPFAM; SSF64268; PX domain; 1.
DR   PROSITE; PS51450; LRR; 6.
DR   PROSITE; PS50195; PX; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; Cell membrane; Coiled coil; Cytoplasm; Endosome;
KW   Leucine-rich repeat; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1502
FT                   /note="Nischarin"
FT                   /id="PRO_0000348267"
FT   DOMAIN          12..122
FT                   /note="PX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00147"
FT   REPEAT          289..310
FT                   /note="LRR 1"
FT   REPEAT          312..333
FT                   /note="LRR 2"
FT   REPEAT          334..355
FT                   /note="LRR 3"
FT   REPEAT          357..378
FT                   /note="LRR 4"
FT   REPEAT          379..400
FT                   /note="LRR 5"
FT   REPEAT          404..425
FT                   /note="LRR 6"
FT   REGION          1..134
FT                   /note="Necessary for binding to phosphoinositide-3-P; not
FT                   sufficient for targeting to endosomes"
FT                   /evidence="ECO:0000250"
FT   REGION          121..693
FT                   /note="Necessary for homooligomerization and targeting to
FT                   endosomes"
FT                   /evidence="ECO:0000250"
FT   REGION          246..867
FT                   /note="Interaction with PAK1"
FT                   /evidence="ECO:0000250"
FT   REGION          481..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          524..549
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          628..684
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          659..867
FT                   /note="Interaction with LIMK"
FT                   /evidence="ECO:0000250"
FT   REGION          707..805
FT                   /note="Interaction with ITGA5"
FT                   /evidence="ECO:0000250"
FT   REGION          1014..1101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          623..692
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        635..650
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        660..684
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         542
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TM9"
FT   MOD_RES         544
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TM9"
FT   MOD_RES         547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TM9"
FT   MOD_RES         1280
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TM9"
FT   MOD_RES         1282
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2I1"
SQ   SEQUENCE   1502 AA;  166503 MW;  E89025E32450ECF8 CRC64;
     MAAATLSFGP EREAEPAKEA RVVGSELVDT YTVYVIQVTD GNHEWTIKHR YSDFHDLHEK
     LVAERKIDKT LLPPKKIIGK NSRSLVEKRE KDLEVYLQTL LKTFPDVAPR VLAHFLHFHL
     YEINGVTAAL AEELFEKGEQ LLGAGEVFAI RPLQLYAITE QLQQGKPTCA SGDAKTDLGH
     ILDFTCRLKY LKVSGTEGPF GTSNIREQLL PFDLSIFKSL HQVEMSHCDA KHVRGLVTSK
     PTLATMSVRF SAASMKEVLV PEASEFDEWE PEGTTLGGPV TAVIPTWQAL TTLDLSHNSI
     SEIDESVKLI PKIEYLDLSH NGVLVVDNLQ HLYNLVHLDL SYNKLSSLEG VHTKLGNVKT
     LNLAGNFLER LSGLHKLYSL VNLDLRDNRI EQLDEVKSIG NLPCLEHVAL LNNPLSIIPD
     YRTKVLSQFG ERASEICLDD VATTEKELDT VEVLKAIQKA KDVKSKLSST EKKVGEDFRL
     PTAPCIRPSS SPPTAVPTSA SLPQPILSNQ GIMFVQEEAL ASSLSSTDSL PPDDRPIAQA
     CSNSMGSLPT GQVAAEDLRD LPGAVGGVSP DHAEPEVQVV PGSGQIIFLP FTCIGYTATN
     QDFIQRLSTL IRQAIERQLP AWIEAANQRE EAHGEQGEEE EEEEEEDVAE SRYFEMGPPD
     AEEEEGSGQG EEDEEDEDEE AEEERLALEW ALGADEDFLL EHIRILKVLW CFLIHVQGSI
     RQFAACLVLT DFGIAVFEIP HQESRGSSQH ILSSLRFVFC FPHGDLTEFG FLMPELCLVL
     KVRHSENTLF IISDAANLHE FHADLRSCFA PQHMAMLCSP ILYGSHTSLQ EFLRQLLTFY
     KVAGGSQERS QGCFPVYLVY SDKRMVQTAA GDYSGNIEWA SCTLCSAVRR SCCAPSEAVK
     SAAIPYWLLL TSQHLNVIKA DFNPMPSRGT HNCRNRNSFK LSRVPLSTVL LDPTRSCTQP
     RGAFADGHVL ELLVGYRFVT AIFVLPHEKF HFLRVYNQLR ASLKDLKTVV IAKNPSARPR
     TQGPLAGGQP AKSRVSAEQR LQETPAEAPA PAPAAAESAA EAPAAAEASA PAGAPAPAGA
     PAPAGAPAGA QAPAPAQAEV PAQYPSERLI QSTSEENQIP SHLPVCPSLQ HIARLRGRAI
     IDLFHSSIAE VENEELRHLL WSSVVFYQTP GLEVTACVLL STKAVYFILH DGLRRYFSEP
     LQDFWHQKNT DYNNSPFHIS QCFVLKLSDL QSVNVGLFDQ YFRLTGSSPT QVVTCLTRDS
     YLTHCFLQHL MLVLSSLERT PSPEPIDKDF YSEFGDKNTG KMENYELIHS SRVKFTYPSE
     EEVGDLTYVV AQKMADPAKN PALSILLYIQ AFQVITPQLG RGRGPLRPKT LLLTSAEIFL
     LDEDYIHYPL PEFAKEPPQR DRYRLDDGRR VRDLDRVLMG YNPYPQALTL VFDDTQGHDL
     MGSVTLDHFG EMPGGPGRAG QGREVQWQVF VPSAESREKL ISLLARQWEA LCGRELPVEL
     TG
//
